Adolfo García-Sastre

Founder at Vivaldi Biosciences, Inc.

Retail Trade

Health Technology

Profile

Adolfo García-Sastre is the founder of Vivaldi Biosciences, Inc. (founded in 2006) and holds the title of Member-Scientific Advisors since 2011.
Dr. García-Sastre is also the founder of CastleVax, Inc...

Adolfo García-Sastre active positions

Companies	Position	Start
Vivaldi Biosciences, Inc. Vivaldi Biosciences, Inc. Drugstore ChainsRetail Trade Vivaldi Biosciences Inc. develops and markets vaccines. It specializes in developing live attenuated influenza vaccines (LAIVs). The company was founded by Eliott Kieff, Peter Palese, and Adolfo García-Sastre in 2006 and is headquartered in Fort Collins, CO.	Founder	2005-12-31

All active positions of Adolfo García-Sastre

Former positions of Adolfo García-Sastre

Companies	Position	End
CastleVax, Inc. CastleVax, Inc. BiotechnologyHealth Technology CastleVax, Inc. is an American vaccine platform company based on technology developed at the Icahn School of Medicine at Mount Sinai, headquartered in an undisclosed location. The private company's platform uses a disease virus to induce the human immune system to produce neutralizing antibodies targeted at a range of emerging and pandemic viruses, including SARS-CoV-2. The technology was developed in response to the growing need for vaccine independence and pandemic response preparedness. CastleVax's leading candidate, NDV-HXP-S, is currently being tested in clinical trials in multiple countries around the world. The company was founded by Florian Krammer, Peter Palese, Adolfo García-Sastre.	Founder	-

See the detail of Adolfo García-Sastre's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Adolfo García-Sastre's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Vivaldi Biosciences, Inc. Vivaldi Biosciences, Inc. Drugstore ChainsRetail Trade Vivaldi Biosciences Inc. develops and markets vaccines. It specializes in developing live attenuated influenza vaccines (LAIVs). The company was founded by Eliott Kieff, Peter Palese, and Adolfo García-Sastre in 2006 and is headquartered in Fort Collins, CO.	Retail Trade
CastleVax, Inc. CastleVax, Inc. BiotechnologyHealth Technology CastleVax, Inc. is an American vaccine platform company based on technology developed at the Icahn School of Medicine at Mount Sinai, headquartered in an undisclosed location. The private company's platform uses a disease virus to induce the human immune system to produce neutralizing antibodies targeted at a range of emerging and pandemic viruses, including SARS-CoV-2. The technology was developed in response to the growing need for vaccine independence and pandemic response preparedness. CastleVax's leading candidate, NDV-HXP-S, is currently being tested in clinical trials in multiple countries around the world. The company was founded by Florian Krammer, Peter Palese, Adolfo García-Sastre.	Health Technology